Trial intelligence / Profile preview

Tranexamic Acid in High Risk Spine Fusion Surgery

NCT01728636Phase 2Completed

Sponsor
Northwestern University
Start
Jan 2013
Primary completion
Dec 2017
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of tranexamic acid in Kyphoscoliosis, sponsored by Northwestern University. Started Jan 2013; status: completed.

02

Drugs

tranexamic acid
03

Conditions

Kyphoscoliosis

Beyond the preview

Go deeper on NCT01728636.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01728636.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call